Overactive Bladder Treatment Market Scope And Analysis

  • Report Code : TIPRE00004082
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 209
Buy Now

Overactive Bladder Treatment Market Analysis, Size, and Growth (2022-2028)

Buy Now

Overactive Bladder Treatment Market Report Overactive Bladder Treatment Market Size and Share Overactive Bladder Treatment Market Scope and Analysis

Overactive Bladder Treatment Market Report Scope

Report Attribute Details
Market size in 2021 US$ 4.3 Billion
Market Size by 2028 US$ 5.33 Billion
Global CAGR (2021 - 2028) 3.1%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Pharmacotherapy
  • Anticholinergics
  • Mirabegron
  • Botox
  • Neurostimulation
  • Intravesical Instillation
By Disease Type
  • Idiopathic Overactive Bladder and Neurogenic Bladder
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Alembic Pharmaceuticals Limited
  • Astellas Pharma Inc
  • Pfizer Inc
  • AbbVie Inc
  • Teva Pharmaceutical Industries Ltd
  • Endo Pharmaceuticals Inc
  • Hisamitsu Pharmaceutical Co Inc
  • Medtronic Plc
  • Colorado Urology Associates PLLC

    • Overactive Bladder Treatment – Market Segmentation

    The global overactive bladder treatment market is analyzed based on pharmacotherapy, disease type, and geography. Based on pharmacotherapy, the overactive bladder treatment market is classified into mirabegron, Botox, neurostimulation, anticholinergics, and intravesical instillation. Based on disease type, the market is divided into idiopathic overactive bladder and neurogenic bladder.Geographically, the overactive bladder treatment market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.  

    Company Profiles

    • Alembic Pharmaceuticals Limited
    • Astellas Pharma Inc
    • AbbVie Inc
    • Teva Pharmaceuticals Industries Ltd
    • Endo Pharmaceuticals Inc
    • Hisamitsu Pharmaceutical Co. Inc
    • Medtronic Plc
    • Colorado Urology Associates, PLLC
    • Axonics Modulation Technologies, Inc
    • Pfizer Inc